Clinical Trial Update: A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the absorption, metabolism, and excretion of GBT440 (voxelotor) in healthy male subjects has completed. The update summarizes the pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Oxbryta (voxelotor)

Snippet

Sponsor: Global Blood Therapeutics | Conditions: Anemia, Sickle Cell | Phase 1 | Status: COMPLETED